Expertise in
5
conditions

Laurence H. Klotz

Toronto, ON, CA 
Expertise in
5
conditions
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Laurence Klotz practices in Toronto, Canada. Mr. Klotz is highly rated in 5 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, COVID-19, Prostatectomy, and Orchiectomy.

His clinical research consists of co-authoring 97 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI: a 3-arm Randomized Controlled Trial Evaluating the Role of 29MHz Micro-ultrasound in Guiding Prostate Biopsy in Men with Clinical Suspicion of Prostate Cancer.
Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI: a 3-arm Randomized Controlled Trial Evaluating the Role of 29MHz Micro-ultrasound in Guiding Prostate Biopsy in Men with Clinical Suspicion of Prostate Cancer.
Enrollment Status: Completed
Publish Date: November 21, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The Prime Study
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The Prime Study
Enrollment Status: Terminated
Publish Date: October 04, 2024
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 3
A Single Blind, Two-Stage Dose Finding Study to Evaluate the Safety, Tolerability and Efficacy of a Single Liproca® Depot Injection Into the Prostate in Patients With Localized Prostate Cancer, Assigned to Active Surveillance Who Are at High Risk for Disease Progression (Followed by an Open Label Extension With a Repeat Injection (Optional)).
A Single Blind, Two-Stage Dose Finding Study to Evaluate the Safety, Tolerability and Efficacy of a Single Liproca® Depot Injection Into the Prostate in Patients With Localized Prostate Cancer, Assigned to Active Surveillance Who Are at High Risk for Disease Progression (Followed by an Open Label Extension With a Repeat Injection (Optional)).
Enrollment Status: Completed
Publish Date: December 21, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Drug, Diagnostic test
Study Phase: Phase 3
View 5 Less Clinical Trials

97 Total Publications

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis-Reply.
Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis-Reply.
Journal: JAMA
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Klotz's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile